학술논문
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
Document Type
Article
Author
Harris, P.A.; Eidam, P.M.; Beal, A.M.; Berger, S.B.; Capriotti, C.A.; Finger, J.N.; Geddes, B.; Gough, P.J.; Hoffman, B.L.; Hoffman, S.J.; Jeong, J.U.; Leister, L.K.; Lich, J.D.; Mahajan, M.K.; Nagilla, R.; Ng, S.-L.; Pasikanti, K.K.; Reilly, M.A.; Rivera, E.J.; Schaeffer, M.C.; Sehon, C.A.; Sun, H.; Bertin, J.; Marquis, R.W.; King, B.W.; Bandyopadhyay, D.; Campobasso, N.; Cox, J.A.; Meslamani, J.; Ouellette, M.T.; Totoritis, R.D.; Ward, P.; Wisnoski, D.D.; White, G.V.; Anderson, N.A.; Campos, S.; Hutchinson, S.E.; Mosley, J.E.; Nassau, P.M.; Thorpe, J.H.; Wellaway, N.; Woolven, J.M.; Faucher, N.; George, N.; Beneton, V.; Daugan, A.; Donche, F.; Fouchet, M.-H.; Grondin, P.; Jigorel, E.; Lamoureux, P.; Potvain, F.; Sautet, S.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 23 May 2019, 62(10):5096-5110)
Subject
Language
English
ISSN
15204804
00222623
00222623